Conference abstract · 28 Sep 2018
Conference abstractPublished 17 Jul 2020
Thinking beyond QbD: Accelerating risk smart development and technology transfer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A risk-smart QbD-based methodology driven by improved Informatics goes beyond tactical & reactive development and streamlining standards-based Technology Transfer by capturing mechanistic understanding to support the probabilistic modeling approach from early ideation through research, development, optimization, and scale-up as well as integrating standards (ISA-88 and ISA-95) and structuring data in a fully searchable format. Moreover, the recognition of lean QbD risk assessment through process knowledge is a product lifecycle issue as opposed to a once and done aspect of development is a good first step. That recognition shall catalyze organizational development whose ultimate goal is a broad organizational understanding and competence in QbD concepts and tools, focusing on top-down approach of technology transfer beyond Product Development to include Operations, Engineering, QA, Regulatory Affairs and even Finance. A DIbD (Data-integratingbased- design) supported QbD strategy that expands Research, Development and Manufacturing enables seamless information from across the organization to support continuous product and process improvement. It offers significant opportunities to accelerates products to market, reduces compliance costs and improves product quality by reducing the number of experiment cycles, speeding individual cycles and facilitating technology transfer between cycles. Consistency and standards driven through informatics enable rapid technology transfer between scientists and systems, while Cloud-based software deployments enable remote organizations to collaborate in the QbD process.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2017
From preclinical to IND formulation development: Using a QbD risk based approach
Perspective · 3 Nov 2025
Accelerating Therapeutic Innovation Through Advanced Drug Development Technologies
Conference abstract · 29 Aug 2016
Accelerating preclinical development for poorly bioavailable compounds by assessing multiple oral technologies in parallel
Research article · 30 Jun 2014
Using ZigBee and RFID technology with GPRS to development of smart home system
More from this journal
The newest in Journal of Pharmacology and Medicinal Chemistry.
Editorial · 1 Dec 2022
Effectiveness of specific Indian medicinal plants in terms of medicine and therapy
Commentary · 1 Dec 2022
Modeling of coronary circulation particles for the development of drug carriers
Commentary · 26 Nov 2022
Redefining drug discovery is deep generative molecular design
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacology and Medicinal Chemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kishor K Chakraborty”

